By day 14, the IgM serum concentration in the tumor group (294.01 ± 122.29 μg/mL, n = 38) decreased, with a significant difference (p = 0.0109) compared to the control group (198.08 ± 49.26 μg/mL, n = 14). This evidence concerns the gene CD40LG and neoplasm.